ClinicalTrials.gg
Sign In
CompletedNCT01759433Updated Dec 31, 2013

Reference Intervals for Sonoclot Analysis in Chinese

An observational study in Cardiovascular Diseases, sponsored by Wuhan Asia Heart Hospital. Completed at 1 site in China. Open to participants aged 18 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2013-12-31.

Sponsored by Wuhan Asia Heart Hospital · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
135
Ages
18 Years to 80 Years
Sex
All
01

Study summary

The reference intervals for Sonoclot Analysis may be different between Chinese and American. So far, no reference interval has been established in Chinese for Sonoclot Analysis. This study is going to establish the first Chinese reference intervals for Sonoclot Analysis and test whether they are different from American reference intervals.

02

Conditions studied

  • Cardiovascular Diseases
03

In context

Cardiovascular Diseases

5,025 studies on the registry are indexed under Cardiovascular Diseases; 928 are open to participants now.

This study's enrollment of 135 is below the median of 600 across 1,524 observational studies indexed under Cardiovascular Diseases.

Browse Cardiovascular Diseases studies →

Lead sponsor

Wuhan Asia Heart Hospital is the lead sponsor of 20 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Chinese healthy adults aged 18 and older

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged 18 and older
  • Han ethnic

Exclusion criteria

Exclusion Criteria:

  • Renal dysfunction
  • Liver disorders
  • Known coagulation disorders
  • Patients taking medications in the last month
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
135 participants (actual)
Patient registry
No
Biospecimen retention
None retained
06

What researchers measure

Primary outcomes

  1. The reference intervals for sonoclot analysis in Chinese

    whether Chinese reference intervals are different from Caucasian reference intervals.

    Time frame: 3 month

07

Study locations

1 site
  • Wuhan Asia Heart hospital
    Wuhan, Hubei 430022, China
08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Dec 2012, a primary completion of Mar 2013 and a completion of Mar 2013. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 29, 2012
First posted
Jan 3, 2013
Start
Dec 2012
Primary completionActual
Mar 2013
CompletionActual
Mar 2013
Last update
Dec 31, 2013
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 31, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01759433
Lead sponsor
Wuhan Asia Heart Hospital
Responsible party
Zhenlu Zhang (Director of the clinical laboratory, Wuhan Asia Heart Hospital) — Principal investigator
First posted
Jan 3, 2013
Start date
Dec 2012
Primary completion
Mar 2013
Completion
Mar 2013
Last update
Dec 31, 2013

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Cardiovascular Diseases →

Other studies from this sponsor

Wuhan Asia Heart Hospital

Start the discussion